Back
Flushing Financial Vs. Keros Therapeutics Industry Stock Comparison
Sell
40
FFIC
Flushing Financial
Last Price:
12.11
Seasonality Move:
0.27%
Sell
25
KROS
Keros Therapeutics
Last Price:
45.37
Seasonality Move:
4.22%
Sell
40
Flushing Financial (FFIC)
is a Sell
Is Flushing Financial a Buy, Sell or Hold?
- The current Flushing Financial [FFIC] share price is $11.91. The Score for FFIC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- FFIC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FFIC Stock Price Chart
What is Flushing Financial's stock price today?
-
The Flushing Financial share price today is $11.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FFIC is experiencing slight buying pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
FFIC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 42.48 | Sell |
| Chaikin Money Flow: | 11095 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.98 - 13) | Sell |
| Bollinger Bands (100): | (11.63 - 13.29) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.91 | Sell |
| Relative Strength Index (14 RSI): | 36.74 | Sell |
| Chaikin Money Flow: | -120480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.18 - 50.06) | Sell |
| Bollinger Bands (100): | (50.42 - 64.92) | Sell |
FFIC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.98 | Sell |
| 20-day SMA: | 12.29 | Sell |
| 50-day SMA: | 12.22 | Sell |
| 200-day SMA: | 13.39 | Sell |
| 8-day EMA: | 12.02 | Sell |
| 20-day EMA: | 12.22 | Sell |
| 50-day EMA: | 12.36 | Sell |
| 200-day EMA: | 13.37 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.5 | Sell |
| 20-day SMA: | 47.57 | Sell |
| 50-day SMA: | 52.43 | Sell |
| 200-day SMA: | 46.94 | Sell |
| 8-day EMA: | 46.46 | Sell |
| 20-day EMA: | 48 | Sell |
| 50-day EMA: | 51.59 | Sell |
| 200-day EMA: | 50.14 | Sell |
Flushing Financial Earnings Growth & FFIC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.14 per share, and an increase next year of $0.40 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
Flushing Financial Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||